
Opinion|Videos|June 29, 2024
Surgical Considerations and Patient Selection for PDS With Ranibizumab
Author(s)Margaret A. Chang, MD, MS
Dr. Margaret Chang details the facility requirements for PDS implantation, the specialized training surgeons need, and crucial factors to consider for the surgical implantation of PDS.
Advertisement
Episodes in this series
- What facilities are required to implant the device, and what specific training does a surgeon need?
- What are the key considerations for the surgical implantation and subsequent refilling of the PDS?
- What are the major adverse effects associated with the PDS, and which patients are not suitable candidates for this delivery system?
- How does the PDS with ranibizumab fit into the treatment landscape that also includes highly durable agents such as faricimab and high-dose aflibercept?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
UPDATE: STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
2
Advancements in femtosecond laser technology benefit surgeons and patients
3
Research supports that iron dysregulation may drive AMD
4
ONL Therapeutics randomizes first patient in phase 2 GALAXY trial evaluating xelafaslatide
5


















































.png)


